What is Boston Scientific's derivative, gross, assets?

Boston Scientific (BSX) reported derivative, gross, assets of $219M in Q1 2026.

How has Boston Scientific's derivative, gross, assets changed year-over-year?

Boston Scientific's derivative, gross, assets decreased by 5.6% year-over-year, from $232M to $219M.

What is the long-term trend for Boston Scientific's derivative, gross, assets?

Over 5 years (2020 to 2025), Boston Scientific's derivative, gross, assets has grown at a -5.6% compound annual growth rate (CAGR), from $242M to $181M.

Boston Scientific BSX Derivative, gross, assets

Derivative, gross, assets at other companies

AbbottABT

——

MedtronicMDT

——

Other financials

Income statement

See full

Revenue$5.2B+11.6%

Gross profit$3.6B+12.6%

Operating income$1.1B+19.5%

Net income$1.3B+99.3%

EPS (diluted)$0.90+100%

Balance sheet

See full

Cash & equivalents$850.0M+146%

Total equity$25.9B+16.4%

Total assets$44.4B+10.5%

Cash flow

See full

Operating cash flow$348.0M-35.7%

CapEx$177.0M-5.4%

Free cash flow$171.0M-51.7%

Valuation

See full

Market cap$66.81B-37.5%

P/E18.8×-34.0×

P/S3.2×-2.8×

Profitability

See full

Gross margin69.2%+0.5pp

Operating margin18.4%+2.2pp

Net margin17.3%+5.7pp

Returns & leverage

See full

Return on equity14.8%+5.2pp

Debt / equity0×-0.5×

Current ratio1.9×+0.4×

Where this comes from

Reported directly by Boston Scientific in its filing.

Tagged under the XBRL concept us-gaap:DerivativeFairValueOfDerivativeAsset.

The official record: Boston Scientific’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about Boston Scientific's derivative, gross, assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Boston Scientific's derivative, gross, assets?: Boston Scientific (BSX) reported derivative, gross, assets of $219M in Q1 2026.
How has Boston Scientific's derivative, gross, assets changed year-over-year?: Boston Scientific's derivative, gross, assets decreased by 5.6% year-over-year, from $232M to $219M.
What is the long-term trend for Boston Scientific's derivative, gross, assets?: Over 5 years (2020 to 2025), Boston Scientific's derivative, gross, assets has grown at a -5.6% compound annual growth rate (CAGR), from $242M to $181M.